MG53 inhibits cellular proliferation and tumor progression in colorectal carcinoma

Cancer is the second leading cause of mortality after cardiovascular diseases in the United States. Chemotherapy is widely used to treat cancers. Since the development of drug resistance is a major contributor towards the failure of chemotherapeutic regimens, efforts have been made to develop novel...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Pranav, Li, Haichang, Zhang, Guan-Nan, Barbuti, Anna Maria, Yang, Yuqi, Lin, Pei-hui, Cai, Chuanxi, Tan, Tao, Ma, Jianjie, Chen, Zhe-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461659/
https://www.ncbi.nlm.nih.gov/pubmed/36147477
http://dx.doi.org/10.7150/ijbs.67869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461659/
https://www.ncbi.nlm.nih.gov/pubmed/36147477
http://dx.doi.org/10.7150/ijbs.67869

Ejemplares similares